Cost-effectiveness of sentinel lymph node biopsy in thin melanomas

被引:114
作者
Agnese, DM [1 ]
Abdessalam, SF [1 ]
Burak, WE [1 ]
Magro, CM [1 ]
Pozderac, RV [1 ]
Walker, MJ [1 ]
机构
[1] Ohio State Univ, Columbus, OH 43210 USA
关键词
D O I
10.1016/S0039-6060(03)00275-7
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Consideration a sentinel lymph node biopsy (SLNB) is recommended for thin melanomas with poor prognostic features; however, few metastases are identified. The purpose of this study was to assess the cost effectiveness of SLNB in this population. Methods. The prospective melanoma database was reviewed to identify Patients with melanomas <1.2 mm thick who had undergone SLNB. Physician and hospital charges were collected from the appropriate billing department. Results. A total of 138 patients were identified over an 8-year period (1994-2002). Two patients with positive SLNs were identified (1.4%), one with a melanoma <1 mm thick. Patient charges for SLNB ranged from $10,096 to $15,223, compared with $1000 to $1740 for wide excision as an outpatient. Using these charges, the cost to identify a single positive SLN would be between $696,600 and $1,051,100. The cost for wide excision would be between $69,000 and $120,100. Assuming that all patients with a positive SLN would die of melanoma, the cost per life saved would be $627,000 to $931,000. Conclusions. The cost of performing SLNB in this population is great and only a small number will have disease identified that will alter treatment. These data call into question the appropriateness of SLNB for thin melanomas.
引用
收藏
页码:542 / 547
页数:6
相关论文
共 23 条
[1]   YEARS OF POTENTIAL LIFE LOST - ANOTHER INDICATOR OF THE IMPACT OF CUTANEOUS MALIGNANT-MELANOMA ON SOCIETY [J].
ALBERT, VA ;
KOH, HK ;
GELLER, AC ;
MILLER, DR ;
PROUT, MN ;
LEW, RA .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 23 (02) :308-310
[2]   Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].
Balch, CM ;
Soong, SJ ;
Gershenwald, JE ;
Thompson, JF ;
Reintgen, DS ;
Cascinelli, N ;
Urist, M ;
McMasters, KM ;
Ross, MI ;
Kirkwood, JM ;
Atkins, MB ;
Thompson, JA ;
Coit, DG ;
Byrd, D ;
Desmond, R ;
Zhang, YT ;
Liu, PY ;
Lyman, GH ;
Morabito, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634
[3]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[4]   Thin ≤1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy [J].
Corsetti, RL ;
Allen, HM ;
Wanebo, HJ .
ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (06) :456-460
[5]   Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (≥4 mm) primary melanoma [J].
Gershenwald, JE ;
Mansfield, PF ;
Lee, JE ;
Ross, MI .
ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (02) :160-165
[6]   Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients [J].
Gershenwald, JE ;
Thompson, W ;
Mansfield, PF ;
Lee, JE ;
Colome, MI ;
Tseng, CH ;
Lee, JJ ;
Balch, CM ;
Reintgen, DS ;
Ross, MI .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :976-983
[7]   Histological characteristics of metastasizing thin melanomas - A case-control study of 43 cases [J].
Guitart, J ;
Lowe, L ;
Piepkorn, M ;
Prieto, VG ;
Rabkin, MS ;
Ronan, SG ;
Shea, CR ;
Tron, VA ;
White, W ;
Barnhill, RL .
ARCHIVES OF DERMATOLOGY, 2002, 138 (05) :603-608
[8]   How to use the results of an economic evaluation [J].
Heyland, DK ;
Gafni, A ;
Kernerman, P ;
Keenan, S ;
Chalfin, D .
CRITICAL CARE MEDICINE, 1999, 27 (06) :1195-1202
[9]  
HOUGHTON AN, 2002, NCCN MELANOMA CANC C
[10]   THIN LEVEL-IV MALIGNANT-MELANOMA - A SUBSET IN WHICH LEVEL IS THE MAJOR PROGNOSTIC INDICATOR [J].
KELLY, JW ;
SAGEBIEL, RW ;
CLYMAN, S ;
BLOIS, MS .
ANNALS OF SURGERY, 1985, 202 (01) :98-103